Keyphrases
Glioblastoma
100%
B Cells
52%
Glioma
41%
CD8+ T Cells
36%
Immunosuppression
27%
Treg
25%
Tumor-evoked Regulatory B Cells
25%
Tumor Microenvironment
22%
Tumor-associated Myeloid Cells
22%
Myeloid-derived Suppressor Cells
22%
Tumor
21%
Programmed Death-ligand 1 (PD-L1)
19%
4-1BBL
19%
Myeloid Cells
18%
B Cell Subsets
18%
Breg
18%
TBregs
16%
Tumor Cells
16%
Phosphorylation
15%
Recurrent Glioblastoma
15%
ERK2
15%
T Cells
14%
Regulatory B Cells
13%
Multiple Sclerosis
12%
Glioblastoma multiforme
12%
In Cancer
12%
Metabolic Switch
11%
Immune Checkpoint Blockade
11%
Aging
11%
Brain Tumor
11%
Radiotherapy
11%
CD8+ T
10%
Murine Model
10%
Immune Response
10%
Clinically Isolated Syndrome
10%
PD-1 Blockade
10%
Anti-PD-1 Immunotherapy
10%
Cerebrospinal Fluid
10%
Malignant Glioma
10%
Oxidative Phosphorylation (OXPHOS)
10%
Glycolytic
10%
Neural Stem Cells
10%
Hypoxia-inducible factor-1α (HIF-1α)
10%
Experimental Autoimmune Encephalomyelitis
10%
B-1 Cells
10%
STING Agonist
10%
Glioma Model
10%
Regulatory T Cells
9%
Microglia
9%
Glioma Cells
9%
Immunology and Microbiology
B Cell
65%
Myeloid
46%
Cytotoxic T-Cell
40%
Immunotherapy
37%
Regulatory T Cell
34%
Regulatory B Cells
33%
Immunity
28%
Immunosuppression
26%
T Cell
23%
Immunosuppressive Drug
19%
Programmed Death-Ligand 1
15%
B Lymphocyte Subpopulation
15%
Tumor Cell
14%
Immunocompetent Cell
13%
Microglia
12%
Multiple Sclerosis
12%
Immune Response
11%
Agonist
10%
Cerebrospinal Fluid
10%
Experimental Autoimmune Encephalomyelitis
10%
Cell Survival
10%
Neural Stem Cell
10%
Oxidative Phosphorylation
10%
CTLA-4
10%
Granzyme B
9%
Clinically Isolated Syndrome
8%
Overall Survival
8%
Immunology
8%
Macrophage
7%
Cell Function
7%
Blood Brain Barrier
7%
Mediator
6%
Chimeric Antigen Receptor T-Cell
6%
CD20
6%
Metabolite
6%
CD8
6%
Immune Checkpoint Blockade
6%
Integrin
6%
Myeloid-Derived Suppressor Cell
5%
T Cell Activation
5%
Dendritic Cell
5%
Cell Proliferation
5%
B Cell Activating Factor
5%
Antigen-Presenting Cell
5%
T Cell Receptor
5%
Platelet-Rich Fibrin
5%
Thymus and Activation Regulated Chemokine
5%
Gamma Urogastrone
5%
Immune Evasion
5%
Hypoxia Inducible Factor 1
5%
Medicine and Dentistry
Glioblastoma
65%
Ganglioglioma
35%
Neoplasm
33%
Immunotherapy
19%
Malignant Neoplasm
16%
Myeloid Cell
15%
Immunity
13%
Tumor Cell
12%
Immunosuppressive Drug
12%
Tumor Microenvironment
11%
Immune Checkpoint Blockade
11%
Intracranial Tumor
10%
Neural Stem Cell
10%
Mitogen Activated Protein Kinase 3
10%
Myeloid-Derived Suppressor Cell
10%
Immunocompetent Cell
8%
Cytotoxic T-Cell
7%
Immunology
7%
B Cell
7%
Regulatory T Cell
7%
Regulatory B Cell
7%
Immunosuppressive Treatment
7%
Clinical Trial
6%
Immune Response
6%
Microglia
6%
Radiation Therapy
6%
Breast Cancer
6%
Metastatic Carcinoma
6%
Tumor Immune Microenvironment
6%
Brain Cancer
5%
Biological Marker
5%
Glioma Cell
5%
Cell Survival
5%
Overall Survival
5%
Tumor Progression
5%
Tucatinib
5%
Macrophage
5%
Checkpoint Kinase 2
5%
Gamma Urogastrone
5%
Epidermal Growth Factor Receptor 2
5%
Repolarization
5%
Platelet-Rich Fibrin
5%
Cell pH
5%
Antigen Presenting Cell
5%
CTLA-4
5%
Chimeric Antigen Receptor T-Cell
5%
Pancreas Adenocarcinoma
5%
Lung Metastasis
5%
Oncolytic Adenovirus
5%
Thymus and Activation Regulated Chemokine
5%
